Pfēnex Expression Technology™ COMMERCIAL LICENSE AGREEMENTCommercial License Agreement • January 23rd, 2006 • Iomai Corp • Pharmaceutical preparations • Delaware
This Agreement is effective as of the latest date of signing below and is by and between Dow Global Technologies Incorporated (“Dow”), a Michigan corporation having its principal offices at 2030 Dow Center, Midland, MI, 48674 USA and Iomai Corporation, a Delaware corporation (“Licensee”) having a principal place of business at 20 Firstfield Road Suite 250, Gaithersburg, MD 20878 USA
AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • January 23rd, 2006 • Iomai Corp • Pharmaceutical preparations • District of Columbia
THIS AMENDED AND RESTATED LICENSE AGREEMENT (this “Agreement”) is effective as of the Effective Date (as defined below), by and between (i) the WALTER REED ARMY INSTITUTE OF RESEARCH (“Licensor”), as the representative of the United States of America, and (ii) IOMAI CORPORATION (“Licensee”), a corporation of Delaware, having a principal place of business at 2421 Pennsylvania Avenue, N.W., Washington, DC 20037-1718.
